Effects of interferon-α therapy on cardiac function in patients with chronic hepatitis B infection

Heart and Vessels

Volumn 19, Issue 6, 2004, Pages 263-266

  Erol, Mustafa Kemal ^a   Erol, Serpil ^a   Koruk, Mehmet ^b   Ertek, Mustafa ^a   Bozkurt, Engin ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Cardiac function; Hepatitis B; Interferon

Indexed keywords

ALPHA2B INTERFERON;

ADULT; ANAMNESIS; ARTICLE; CARDIOTOXICITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; FLOW RATE; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION TIME; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEPATITIS B; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; VENTRICULAR FUNCTION, LEFT;

EID: 10044282516     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-004-0780-x     Document Type: Article

References (11)

1. Vial T, Descotes J (1994) Clinical toxicity of the interferons. Drug Saf 10:115-150
2. Dusheiko G (1997) Side effects of alpha interferon in chronic hepatitis C. Hepatology 26(3 suppl 1):112S-121S
3. Teragawa H, Hondo T, Amano H, Hino F, Ohbayashi M (1996) Adverse effects of interferon on cardiovascular system in patients with chronic hepatitis C. Jpn Heart J 37:905-915
4. Iarussi D, Di Salvo G, Pergola V, Copploino P, Tadesco MA, Ratti G, Esposito L, Calabro R, Ferrara M (2003) Pulsed Doppler tissue imaging and myocardial function in thalassemi major. Heart Vessels 18:1-6
5. Yamamoto T, Tsuchihashi T, Hayashi J, Kashiwagi S (1998) Effect of interferon therapy on heart rate and sympathetic nervous system. Fukuoka Igaku Zasshi 89:207-215
6. Fukuhara M, Matsumura K, Ohmori S, Yanai T, Tsubota Y, Abe I, Fujishima M (1999) Effects of interferon on circadian changes in blood pressure and hart rate variability in patients with chronic hepatitis. Am J Hypertens 12:519-523
7. Kadayifci A, Aytemir K, Arslan M, Aksoyek S, Sivri B, Kabakci G (1997) Interferon-alpha does not cause significant cardiac dysfunction in patients with chronic active hepatitis. Liver 17: 99-102
8. Sartori M, Andorno S, La Terra G, Pozzli G, Rudoni M, Sacchetti GM, Inglese E, Aglietta M (1995) Assessment of interferon cardiotoxicity with quantitative radionuclide angiography. Eur J Clin Invest 25:68-70
9. Kouno H, Aimitsu S, Ikemoto Y, Nakanishi T, Kajiyama G (1994) Cardiovascular complications of interferon therapy in chronic hepatitis C. Nippon Rinsho 52:1914-1918
10. Sato Y, Takatsu Y, Yamada T, Kaaoka K, Taniguchi R, Mimura R, Sasayama S, Matsumori A (2000) Interferon treatment for dilated cardiomyopathy and striated myopathy associated with hepatitis C virus infection based on serial measurements of serum concentrations of cardiac troponin T. Jpn Circ J 64:321-324
11. Parrents E, Chevalier JM, Rougier M, Douard H, Labbe L, Quinino G, Broustet A, Broustet JP (1999) Third degree atrioventricular block induced by interferon alpha. Report of a case. Arch Mal Coeur Vaiss 92:53-56